Merck and Ridgeback Reveal Their Covid-19 Pill Reduces Hospitalization and Death by 50%

A drug that is capable of preventing the worst result of covid-19 may finally come to our rescue anytime soon. On the 1st of October being Friday, pharmaceutical companies Merck and Ridgeback Biotherapeutics publicized the preliminary outcome of a big trial testing out their experimental antiviral medication referred to as molnupiravir.